MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, MSI2 plays a critical role in chronic myelogenous leukaemia (CML) progression 19, and high MSI2 expression predicts an unfavourable outcome in acute myeloid leukaemia (AML) 20.